Zinc oxide 0.4 MG/MG Topical Ointment — RxCUI 244638
RxNorm drug concept · Semantic clinical drug
RxCUI 244638
Semantic clinical drug · SCD
● Current RxNorm concept 14 FDA products
16 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI244638
Official nameZinc oxide 0.4 MG/MG Topical Ointment
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asZNO 0.4 MG/MG Topical Ointment; zinc oxide 40 % Topical Ointment
FDA products mapped14
Package NDCs mapped16
Reported Medicaid activity (SDUD)1,113 prescriptions · 10 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
🕸️ Concept Web — How Zinc oxide 0.4 MG/MG Topical Ointment Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Zinc oxide 0.4 MG/MG Topical Ointment
RxCUI 244638 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Zinc oxide
11423IN
-
Zinc oxide
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Desitin
216498BN
-
Desitin
-
Dose forms 6
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Zinc oxide Topical Ointment
374474SCDF -
Zinc oxide Topical Product
1163041SCDG -
Zinc oxide Topical Ointment [Desitin]
367421SBDF -
Desitin Topical Product
1174516SBDG -
Topical Ointment
316985DF -
Topical Product
1151122DFG
-
Zinc oxide Topical Ointment
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Zinc oxide 0.4 MG/MG
333483SCDC -
Zinc oxide 0.4 MG/MG Topical Ointment [Desitin]
260502SBD -
Zinc oxide 0.4 MG/MG [Desitin]
574277SBDC
-
Zinc oxide 0.4 MG/MG
Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Zinc oxide 0.4 MG/MG
SCDC · 333483 -
Zinc oxide Topical Ointment
SCDF · 374474 -
Zinc oxide Topical Product
SCDG · 1163041
Brand-Name Concepts
-
Zinc oxide 0.4 MG/MG Topical Ointment [Desitin]
SBD · 260502 -
Zinc oxide 0.4 MG/MG [Desitin]
SBDC · 574277 -
Zinc oxide Topical Ointment [Desitin]
SBDF · 367421 -
Desitin Topical Product
SBDG · 1174516 -
Desitin
BN · 216498
📦 FDA Products & Package NDCs
14 products · 16 package NDCs
16 package NDCs map to RxCUI 244638 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 11527-0058-40 | 1 TUBE in 1 CARTON (11527-058-40) / 28 g in 1 TUBE | Dr. Sheffield Diaper Rash | Sheffield Pharmaceuticals LLC | 2014-01-17 |
| 11527-0058-41 | 1 TUBE in 1 CARTON (11527-058-41) / 56 g in 1 TUBE | Dr. Sheffield Diaper Rash | Sheffield Pharmaceuticals LLC | 2002-01-09 |
| 11822-0534-01 | 1 TUBE in 1 PACKAGE (11822-0534-1) / 113 g in 1 TUBE | Zinc Oxide | Rite Aid Corporation | 2022-08-24 |
| 26052-0028-01 | 85 g in 1 TUBE (26052-028-01) | BURTS BEES BABY BEE DIAPER RASH | BURT'S BEES, INC. | 2015-05-29 |
| 26052-0028-02 | 1 TUBE in 1 CARTON (26052-028-02) / 85 g in 1 TUBE | BURTS BEES BABY BEE DIAPER RASH | BURT'S BEES, INC. | 2015-05-29 |
| 41163-0020-26 | 1 TUBE in 1 CARTON (41163-020-26) / 113 g in 1 TUBE | Diaper Rash | United Natural Foods, Inc. dba UNFI | 2009-11-18 |
| 67091-0020-26 | 1 TUBE in 1 CARTON (67091-020-26) / 113 g in 1 TUBE | Diaper Rash | WinCo Foods, LLC | 2022-08-01 |
| 67234-0001-01 | 1 TUBE in 1 BOX (67234-001-01) / 42.5 g in 1 TUBE | Natureplex Diaper Rash | Natureplex LLC | 2005-01-02 |
| 68016-0128-20 | 113 g in 1 TUBE (68016-128-20) | DiaperRashOintment | Pharmacy Value Alliance, LLC | 2018-02-28 |
| 69396-0152-01 | 113 g in 1 TUBE (69396-152-01) | Best Choice Diaper Rash | Trifecta Pharmaceuticals USA LLC | 2024-06-27 |
| 69842-0058-20 | 1 TUBE in 1 CARTON (69842-058-20) / 113.4 g in 1 TUBE | CVS Health Diaper Rash | CVS Health | 2010-03-31 |
| 70000-0469-01 | 72 BOX in 1 CASE (70000-0469-1) / 1 TUBE in 1 BOX / 113 g i... | Zinc Oxide 40% | Cardinal Health | 2019-01-30 |
| 72288-0989-26 | 1 TUBE in 1 CARTON (72288-989-26) / 113 g in 1 TUBE | Zinc Oxide | Amazon.com Services LLC | 2026-01-27 |
| 81929-0002-01 | 1 TUBE in 1 CARTON (81929-002-01) / 50 g in 1 TUBE | Vitacilina Bebe Diaper Rash | Taisho Pharmaceutical California Inc. | 2022-07-01 |
| 83324-0042-01 | 113 g in 1 TUBE (83324-042-01) | Quality Choice Diaper Rash | Chain Drug Marketing Association Inc. | 2024-05-31 |
| 87236-0018-04 | 113 g in 1 TUBE (87236-018-04) | Diaper Rash | Aldermed Inc. | 2025-12-01 |
Observed labelers:
BURT'S BEES, INC. (2) ·
Sheffield Pharmaceuticals LLC (2) ·
Aldermed Inc. (1) ·
Amazon.com Services LLC (1) ·
Cardinal Health (1) ·
Chain Drug Marketing Association Inc. (1)
· +8 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.